CKW Financial Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,940
| Closed | -$133K | – | 219 |
|
|
2024
Q4 | $133K | Hold |
3,940
| – | – | 0.02% | 74 |
|
|
2024
Q3 | $159K | Hold |
3,940
| – | – | 0.02% | 65 |
|
|
2024
Q2 | $151K | Hold |
3,940
| – | – | 0.02% | 67 |
|
|
2024
Q1 | $167K | Hold |
3,940
| – | – | 0.02% | 65 |
|
|
2023
Q4 | $146K | Hold |
3,940
| – | – | 0.02% | 69 |
|
|
2023
Q3 | $143K | Hold |
3,940
| – | – | 0.02% | 65 |
|
|
2023
Q2 | $140K | Hold |
3,940
| – | – | 0.02% | 71 |
|
|
2023
Q1 | $140K | Buy |
3,940
+400
| +11% | +$14K | 0.02% | 57 |
|
|
2022
Q4 | $124K | Buy |
3,540
+100
| +3% | +$3.33K | 0.02% | 60 |
|
|
2022
Q3 | $101K | Hold |
3,440
| – | – | 0.02% | 72 |
|
|
2022
Q2 | $188K | Sell |
3,440
-800
| -19% | -$44.2K | 0.03% | 47 |
|
|
2022
Q1 | $233K | Buy |
4,240
+800
| +23% | +$43.5K | 0.03% | 43 |
|
|
2021
Q4 | $190K | Hold |
3,440
| – | – | 0.03% | 39 |
|
|
2021
Q3 | $164K | Hold |
3,440
| – | – | 0.03% | 48 |
|
|
2021
Q2 | $173K | Hold |
3,440
| – | – | 0.03% | 50 |
|
|
2021
Q1 | $153K | Buy |
3,440
+1,040
| +43% | +$47.2K | 0.03% | 48 |
|
|
2020
Q4 | $110K | Buy |
2,400
+320
| +15% | +$14.7K | 0.02% | 60 |
|
|
2020
Q3 | $97K | Hold |
2,080
| – | – | 0.02% | 65 |
|
|
2020
Q2 | $106K | Hold |
2,080
| – | – | 0.02% | 52 |
|
|
2020
Q1 | $97K | Hold |
2,080
| – | – | 0.03% | 54 |
|
|
2019
Q4 | $122K | Sell |
2,080
-80
| -4% | -$4.45K | 0.02% | 59 |
|
|
2019
Q3 | $114K | Hold |
2,160
| – | – | 0.02% | 54 |
|
|
2019
Q2 | $108K | Hold |
2,160
| – | – | 0.02% | 62 |
|
|
2019
Q1 | $113K | Hold |
2,160
| – | – | 0.02% | 52 |
|
|
2018
Q4 | $103K | Sell |
2,160
-240
| -10% | -$11.8K | 0.02% | 54 |
|
|
2018
Q3 | $120K | Hold |
2,400
| – | – | 0.02% | 54 |
|
|
2018
Q2 | $121K | Hold |
2,400
| – | – | 0.03% | 48 |
|
|
2018
Q1 | $117K | Buy |
2,400
+1,040
| +76% | +$48.4K | 0.03% | 47 |
|
|
2017
Q4 | $60K | Buy |
+1,360
| New | +$62.8K | 0.01% | 79 |
|
|
2015
Q3 | – | Sell |
-720
| Closed | -$37K | – | 216 |
|
|
2015
Q2 | $37K | Hold |
720
| – | – | 0.01% | 135 |
|
|
2015
Q1 | $42K | Hold |
720
| – | – | 0.02% | 126 |
|
|
2014
Q4 | $38K | Sell |
720
-1,083
| -60% | -$60.6K | 0.02% | 132 |
|
|
2014
Q3 | $104K | Sell |
1,803
-160
| -8% | -$9.81K | 0.05% | 57 |
|
|
2014
Q2 | $133K | Hold |
1,963
| – | – | 0.07% | 40 |
|
|
2014
Q1 | $130K | Sell |
1,963
-353
| -15% | -$23.9K | 0.06% | 43 |
|
|
2013
Q4 | $155K | Buy |
+2,316
| New | +$150K | 0.08% | 37 |
|
Other funds holding GSK
JEST
CKW Financial Group's GSK Position: Q1 2025 in Review
CKW Financial Group sold out of GSK (GSK) in Q1 2025, closing a stake of 3,940 shares — an estimated $133K sold.
CKW Financial Group first reported a position in GSK in Q4 2013 and held it in 36 quarters. The position peaked at $233K in Q1 2022. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.
- CKW Financial Group reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
- CKW Financial Group sold 3,940 GSK shares in Q1 2025, an estimated $133K.
- CKW Financial Group first reported a position in GSK in Q4 2013 and held it in 36 quarters.
- CKW Financial Group's GSK position peaked at $233K in Q1 2022.
- 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.
Based on CKW Financial Group's 13F filing for Q1 2025, filed 16 May 2025.